Skip to main content
OpenTrials

Clinical trial condition

Alpha 1-Antitrypsin Deficiency

Explore clinical trials studying Alpha 1-Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

33 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Alpha 1-Antitrypsin Deficiency trial results

Recruiting

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

NCT06389877

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Clinical Study Center Birmingham, Alabama, United States
  • Clinical Study Center Boston, Massachusetts, United States
  • Clinical Study Center Charleston, South Carolina, United States
  • Clinical Study Center Adelaide, Australia
View Trial Details
Recruiting

PiMZ Longitudinal Cohort (PiMZ Logic)

NCT06505603

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California- Los Angeles Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University Hospital (UZ) Leuven Leuven, Belgium
  • Tays Central Hospital Tampere, Finland
  • Beaumont Hospital Dublin, Ireland
  • Leiden University Medical Center (LUMC) Leiden, ZA, Netherlands
View Trial Details
Recruiting

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

NCT06049082

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida, Gainesville Gainesville, Florida, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • Renovatio Clinical The Woodlands, Texas, United States
View Trial Details
Recruiting

Alpha-1 Research Registry

NCT04157049

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Alpha-1 Foundation Coral Gables, Florida, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)

NCT03945292

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Research Site 5 Birmingham, Alabama, United States
  • Research Site 9 Phoenix, Arizona, United States
  • Research Site 14 La Jolla, California, United States
  • Research Site 17 Los Angeles, California, United States
View all 21 locations
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details

Related conditions